2025: Medsi sold a 25% stake in Bioniq to ex-CEO of Gazprom Media Technologies Fedor Viktorov
The Medsi group of companies sold a 25% stake in Bayonic-Medsi LLC for ₽37 million to Fedor Viktorov. This became known on February 10, 2025. The amount is stated in the company's IFRS statements.
Vadim Fedotov is the former CEO of Gazprom Media Technologies and Groupon Russia. It established Bioniq in 2019 in London. The company also has branches in Switzerland, Germany, the UAE and the USA.
According to Vedomosti, Medsi has found signs of impairment of investments in Bayonic-Medsi due to the unprofitability of the project. In 2023, with revenue growing by 14.5% to ₽147,7 million, the company's loss increased by 68% to ₽118,2 million.
Initially, Medsi invested ₽500 million in the project, while receiving an advance for the same amount for the provision of services to customers for seven years. By the end of 2024, ₽265 million remained of this advance. Medsi's revenue from services provided by Bayonic-Medsi amounted to ₽41 million in 2023 and ₽73 million in 2024.
The owner of the Lab4U service, Valery Savanovich, explained that Bioniq was focused on the premium segment, but Russian consumers are not ready to pay for tests for vitamins in excess of the cost of the vitamin complexes themselves.
The founder of the medical and technological company Reztom Aleksei Remez noted that there are more than 50 analogues of Bioniq on the world market. According to him, the segment of personalized vitamins is growing by 10-15% per year, but in Russia the project faced high competition and skeptical attitude of the audience.
Bioniq proposes to make a personal unloading of recommendations for taking vitamins and minerals based on blood tests. At the same time, the company itself can produce the necessary vitamin complex in Switzerland in accordance with the recommendations. Checkup (comprehensive examination of the body), consultation on its results and recommendations on vitamins will cost 20,000 rubles, and all this, taking into account the cost of the vitamin complex for a year (maximum offer in price) - 130,000 rubles, follows from the information on the Bayonic-Medsi website[1]
2020: Building a company
At the end of February 2020, Medsi and Bioniq Health-tech Solutions announced the creation of the Bayonic-Medsi enterprise, within which the companies will develop a digital personalized system for monitoring and promoting public health. The new business will be headed by Vadim Fedotov, founder of the international company Bioniq Health-tech Solutions, formerly CEO of Gazprom-Media Technologies.
The platform is being created in order to prevent diseases and continuously improve the health indicators of Russians. Bioniq will combine a system for monitoring personal medical indicators using artificial intelligence, consulting support of expert doctors, the development and adjustment of a healthy lifestyle program and other personalized solutions, including a diet, a training plan and vitamin and mineral complexes. This is the first federal program of comprehensive medical support in Russia aimed at strengthening the health of the nation.
You can connect to the Bioniq platform online on the bioniq.com website or in any of the Medsi clinics. Medical specialists will perform an advanced biochemical blood test, on the basis of which personal solutions will be developed. You can undergo an examination at the clinic or at home. Bioniq creates a personal account for each user: it will be possible to familiarize yourself with the results and recommendations of specialists, make a second appointment, get an online consultation and call a nurse to take biomaterial. Genetic testing, microbiota analysis and other tests are also planned to be added to the survey.
 | Deep integration into the network of clinics and the Medsi digital system will allow us to provide every Russian with an affordable tool for systematic and safe biohacking under the control of medical specialists, "said Vadim Fedotov, head of Bioniq. |  |
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |